Oncolytic myxoma virus: The path to clinic
See on Scoop.it – Virology and Bioinformatics from Virology.ca
Highlights•
MYXV is a candidate oncolytic virus with varying efficacies of oncolytic properties.
•
MYXV productively infects many classes of human cancer cells.
•
MYXV discriminates cancerous human myeloid cells from the normal CD34+ stem cells.
•
MYXV is an attractive ex vivo purging agent candidate for hematological malignancies.
•
MYXV possesses significant oncolytic potential for pancreatic cancer and gliomas.
See on www.sciencedirect.com
